from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1722/-

LFCtreatmentdescriptionclass of inhibitor

0.006

Amikacinug/mL Amikacintranslation

0.025

Cap5-10ug/mL Capreomycintranslation

2.052

Rox10-50 ug/mL Roxithromycintranslation

-0.091

SM2-5 ug/mL Streptomycintranslation

-0.667

Tet5-10 ug/mL Tetracyclinetranslation

0.186

Rif0.2-5ug/mL Rifampicintranscription

0.277

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.614

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.947

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.640

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.101

Clofazimine10-13 ug/mL Clofaziminerespiration

0.281

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.950

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.932

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.836

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.633

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.130

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.997

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.351

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.681

KCN5-20 ug/mL Potassium cyaniderespiration

-0.748

NaN30.2-2 mM Sodium aziderespiration

1.279

Nigericin50 uM Nigericinrespiration

1.359

TRC10-150 ug/mL Triclosanrespiration

-1.387

TRZ10-25 ug/mL Thioridazinerespiration

-0.702

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.464

menadione6-10 ug/mL Menadionerespiration

-0.333

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.077

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.093

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.729

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.371

NRP_1Non-replicating persistence stage 1dosRassociated

0.283

Amp0.2mg/mL AmpicillincellWall

0.407

Cephalexin20-100 ug/mL CephalexincellWall

0.164

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.090

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.433

EMB10-20 ug/mL EthambutolcellWall

-0.430

Eta12-40 ug/mL EthionamidecellWall

-0.370

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.409

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.690

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.849

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.048

BZA0.12 mg/mL BenzamidearomaticAmides

0.011

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.301

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.028

H2O24 mM hydrogen peroxideDNAdamaging

0.340

Levo10 ug/mL LevofloxacinDNAdamaging

0.617

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.691

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.093

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.183

UVUV-irradiationDNAdamaging

-1.388

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.408

Antimycin12.5-50 ug/mL Antimycin A?

0.673

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.707

PA_110-50 ug/mL Antitubercular compound PA-1?

0.687

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.418

PA8240.2-2 ug/mL PA-824?

-1.462

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.340

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.435

Verapamil50 uM Verapamil?

0.481

mercaptoethanol2 mM 2-Mercaptoethanol?

0.546

methoxatin10-20 ug/mL Methoxatin?